Effect of hyperthermia on the viability and proliferative activity of tumor cells
- Authors: Anisimova N.Y.1, Kiselevskiy M.V1, Abdullaev A.G.1, Malakhova N.V1, Sitdikova S.M1, Polotskiy B.E1, Davydov M.M1
-
Affiliations:
- Blokhin Russian Cancer Research Center
- Issue: Vol 21, No 5 (2016)
- Pages: 250-252
- Section: Articles
- URL: https://journals.rcsi.science/1028-9984/article/view/40307
- DOI: https://doi.org/10.18821/1028-9984-2016-21-5-250-252
- ID: 40307
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
N. Yu Anisimova
Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
M. V Kiselevskiy
Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
Amir G. Abdullaev
Blokhin Russian Cancer Research Center
Email: amirdo@mail.ru
MD, PhD, Senior researcher of the Thoracic Department of the Research Institute of Clinical Oncology Moscow, 115478, Russian Federation
N. V Malakhova
Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
S. M Sitdikova
Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
B. E Polotskiy
Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
M. M Davydov
Blokhin Russian Cancer Research CenterMoscow, 115478, Russian Federation
References
- Wang H., Wang X., Ju Y., Wang J., Zhang X., Cheng Y. et al. Clinicopathological features and prognosis of pseudomyxoma peritonei. Exp. Ther. Med. 2014; 7 (1): 185-90.
- Chua T..C, Moran B.J., Sugarbaker P.H., Levine E.A., Glehen O., Gilly F.N. et al. Early- and long-term outcome data of patients with pseudomxyoma perontonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J. Clin. Oncol. 2012; 30: 2449-56.
- Robella M., Vaira M., Mellano A., Marsanic P., Cinquegrana A., Borsano A. et al. Treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery and HIPEC. Ann. Surg. Oncol. 2014; 21 (4): 1159-65.
- Oleson J.R., Calderwood S.K., Coughlin C.T. et al. Biological and clinical aspects of hyperthermia in cancer therapy. Am. J. Clin. Oncol. 1988; 11: 368-80.
- Elias D., Raynard B., Boige V., Laplanche A. Estphan G., Malka D., Pocard M. Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. J. Surg. Oncol. 2005; 90: 220-5.
- Glehen O., Cotte E., Brigand C., Arvieux C., Sayag-Beaujard A.C., Gilly F.N. Therapeutic innovations in the management of peritoneal carcinomatosis from digestive origin: Cytoreductive surgery and intraperitoneal chemotherapy. Rev. Med. Int. 2006; 27: 382-91.
- Smeenk R.M., Verwaal V.J., Zoetmulder F.A. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei-a report of 103 procedures. Eur. J. Surg. Oncol. 2006; 32: 186-90.